January 15, 2020

News

Excellent result of FluoGuide’s FG001 guiding surgical removal of cancer is published

FluoGuide A/S’s (“FluoGuide”) compound FG001 lights up the cancer and its invasive growth and has demonstrated potential to vastly improve the... [Read more]

January 9, 2020

Press release

Safety study initiated with FG001

FluoGuide A/S (“FluoGuide”) hereby announces that the first in vivo dosing of FG001 will commence today. This is an important milestone... [Read more]

January 7, 2020

Press release

FluoGuide strengthen its protection on FG001 with the European granting of patent

FluoGuide A/S (“FluoGuide”) is pleased to announce the grant of European patent No. EP3193945 “uPAR targeting peptide for use in peroperative... [Read more]

November 29, 2019

Press release

Interim Report Third Quarter 2019

FluoGuide A/S (“FluoGuide”) today announces its results for the period 01/July/2019 – 30/Sep/2019. The full report is available on the company’s... [Read more]

November 25, 2019

News

FluoGuide presentation at Sedermeradagen in Stockholm and Investordagen in Aalborg

FluoGuide A/S’s (“FluoGuide”) presented the company and its preparation of FG001 for the proof-of-concept study progresses accordingly to plan. At Sedermeradagen... [Read more]

November 25, 2019

Press release

FluoGuide A/S: Change of report date

FluoGuide A/S will publish its interim report for third quarter 2019 on 29 November 2019. Previously communicated date was 30 November... [Read more]

September 20, 2019

News

Presentation of FluoGuide at Life Science Investorkonference Q3 2019

Presentation from FluoGuide at Life Science Investorkonference FluoGuide A/S (“FluoGuide”, ticker FLUO) was presented at the 18 September at the Life... [Read more]

September 7, 2019

Press release

Presentation of data where FG001 demonstrates dose-depended effectiveness in lightening up glioblastoma in a preclinical model

FluoGuide A/S’s (“FluoGuide”, ticker FLUO) compound FG001 lights up the cancer and has in preclinically studies demonstrated potential to vastly improve... [Read more]

September 6, 2019

Press release

Presentation of data where use of FG001 demonstrates improved surgical outcome in metastatic pancreatic cancer compared to standard surgery using only white light

FluoGuide A/S’s (“FluoGuide”, ticker FLUO) compound FG001 lights up the cancer and has in preclinically studies demonstrated potential to vastly improve... [Read more]